Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.6.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.6.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.6.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GW.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GW.5.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GW.5.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GW.5.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GW.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used